Using a score that assesses modifiable risk factors could be used to address racial disparities in stroke prevention, ...

Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.

Andrew Wilner interviews Victor Sung about a phase 1/2 trial on AMT-130, an investigational gene therapy for Huntington disease. This novel approach blocks the mutant protein without changing the DNA.

A single pill consisting of two or more medications may help improve outcomes in hypertension, according to a new American ...

Latine adults with hidradenitis suppurativa report unmet wound care and pain needs, perceived discrimination, and challenges ...

Targeted clinical review during a high-risk phase of care allows early intervention and prevents patient deterioration, thus reducing potential hospital admission.

At least one study reports that students in existing 3-year programs felt as prepared as their peers who had been in a traditional program.

A healthy adult with severe rectal pain and constipation required endoscopic and operative evaluation after ingestion of ...

New EU guidance outlines steps on prevention, screening, and access to care as cardiovascular deaths are projected to climb sharply in coming decades.

A rise in reports of psychosis-like symptoms is increasing pressure on companies and policymakers to address the potential ...

Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...

The report comes as Congress has adjourned for the year without restoring enhanced premium subsidies for millions enrolled in ...